Literature DB >> 6391167

Teratogenicity of anticonvulsant drugs. I: Review of the literature.

T E Kelly.   

Abstract

Mesh:

Substances:

Year:  1984        PMID: 6391167     DOI: 10.1002/ajmg.1320190302

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


× No keyword cloud information.
  12 in total

Review 1.  Drug-induced congenital defects: strategies to reduce the incidence.

Authors:  M De Santis; B Carducci; A F Cavaliere; L De Santis; G Straface; A Caruso
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

Review 2.  The offspring of epileptic mother.

Authors:  S K Tamer; S Misra; S Jaiswal
Journal:  Indian J Pediatr       Date:  1996 Jul-Aug       Impact factor: 1.967

3.  Teratogenic Effects of `Recreational' Drugs: Increasing the risk of congenital anomalies.

Authors:  J E Polifka; J M Friedman
Journal:  Can Fam Physician       Date:  1991-09       Impact factor: 3.275

Review 4.  Craniofacial malformations and their association with brain development: the importance of a multidisciplinary approach for treatment.

Authors:  Asher Ornoy
Journal:  Odontology       Date:  2019-06-06       Impact factor: 2.634

5.  Prescribing in pregnancy. Identifying abnormalities.

Authors:  M J Whittle; K P Hanretty
Journal:  Br Med J (Clin Res Ed)       Date:  1986-12-06

6.  Spina bifida and cleft lip among newborns of Norwegian women with epilepsy: changes related to the use of anticonvulsants.

Authors:  P B King; R T Lie; L M Irgens
Journal:  Am J Public Health       Date:  1996-10       Impact factor: 9.308

7.  A clinical study of 57 children with fetal anticonvulsant syndromes.

Authors:  S J Moore; P Turnpenny; A Quinn; S Glover; D J Lloyd; T Montgomery; J C Dean
Journal:  J Med Genet       Date:  2000-07       Impact factor: 6.318

8.  Long term health and neurodevelopment in children exposed to antiepileptic drugs before birth.

Authors:  J C S Dean; H Hailey; S J Moore; D J Lloyd; P D Turnpenny; J Little
Journal:  J Med Genet       Date:  2002-04       Impact factor: 6.318

9.  Can we ensure the safe use of known human teratogens? Introduction of generic isotretinoin in the US as an example.

Authors:  Margaret A Honein; Cynthia A Moore; J David Erickson
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

Review 10.  The role of active metabolites in drug toxicity.

Authors:  M Pirmohamed; N R Kitteringham; B K Park
Journal:  Drug Saf       Date:  1994-08       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.